1
项与 Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal) 相关的临床试验 / Unknown status临床1/2期IIT An Exploratory, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Anti-minor Histocompatibility Complex (MiHA) Donor T-lymphocytes Expanded ex Vivo, in Patients With a Hematologic Malignancy, With Molecular or Clinical Relapse After Hematopoietic Stem Cell Transplantation From a Matched Donor
This study will evaluate the safety of infusing an anti-MiHA T cell line in patients suffering from an hematologic malignancy that has relapsed following hematopoietic stem cell transplantation from a matched donor.
100 项与 Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal) 相关的临床结果
100 项与 Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal) 相关的转化医学
100 项与 Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal) 相关的专利(医药)
100 项与 Anti-MiHA T cell(CIUSSS de l'Est de l'ile de Montreal) 相关的药物交易